Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-dfsvx Total loading time: 0 Render date: 2024-04-29T21:23:38.894Z Has data issue: false hasContentIssue false

33 - Tuberculosis

from Part I - Systems

Published online by Cambridge University Press:  15 December 2009

By
Adithya Cattamanchi  and
Payam Nahid
Edited by
Rachel L. Chin
Adithya Cattamanchi
Affiliation:
Fellow in Pulmonary and Critical Care Medicine, University of California, San Francisco School of Medicine, San Francisco General Hospital, San Francisco, CA
Payam Nahid
Affiliation:
Assistant Professor of Medicine, Division of Pulmonary and Critical Care, University of California, San Francisco School of Medicine, San Francisco General Hospital, San Francisco, CA
Rachel L. Chin
Affiliation:
University of California, San Francisco
Get access

Summary

INTRODUCTION – AGENT

Mycobacterium tuberculosis is a large, nonmotile, curved rod that causes the vast majority of human tuberculosis cases. M. tuberculosis and three very closely related mycobacterial species (M. bovis, M. africanum, and M. microti) all cause tuberculous disease, and they comprise what is known as the M. tuberculosis complex. M. tuberculosis is an obligate aerobe, accounting for its predilection to cause disease in the well-aerated upper lobes of the lung. However, M. tuberculosis can persist in a dormant state for many years even with a limited oxygen supply. The organisms also persist in the environment and are resistant to disinfecting agents.

Mycobacterium species are classified as acid-fast organisms because of their ability to retain certain dyes when heated and treated with acidified compounds. Humans are the only known reservoir of infection.

EPIDEMIOLOGY

Tuberculosis is the second leading cause of death related to an infectious disease. Nearly one-third of the world's population is infected with Mycobacterium tuberculosis. In 2005, the World Health Organization (WHO) estimated there were 8.8 million new cases of tuberculosis and 1.6 million deaths due to the disease. Tuberculosis is the leading cause of death among human immunodeficiency virus (HIV)-infected persons, accounting for 12% of worldwide deaths. Whereas the average person infected with Mycobacterium tuberculosis has a 10% lifetime chance of developing active disease, immunocompromised patients can have their risk jump to that same percentage annually.

Type
Chapter
Information
Emergency Management of Infectious Diseases , pp. 175 - 184
Publisher: Cambridge University Press
Print publication year: 2008

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

American Thoracic Society and the Centers for Disease Control and Prevention (CDC). Targeted tuberculin testing and treatment of latent tuberculosis infection. Am J Respir Crit Care Med 2000 Apr;161:S221–47.CrossRef
American Thoracic Society, Centers for Disease Control and Prevention and Infectious Disease Society of America. Treatment of tuberculosis. MMWR 2003;52(RR-11).
Blumberg, H M, Burman, W J, Chaisson, R E, et al. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med 2003;167:603–62.Google ScholarPubMed
Blumberg, H M, Leonard, M K Jr, Jasmer, R M. Update on the treatment of tuberculosis and latent tuberculosis infection. JAMA 2005;293:2776–84.CrossRefGoogle ScholarPubMed
Cattamanchi, A, Hopewell, P C, Gonzalez, L C, et al. A 13-year molecular epidemiological analysis of tuberculosis in San Francisco. Int J Tuberc Lung Dis 2006;10:297–304.Google ScholarPubMed
Hass, D W, Prez, Des R M. Tuberculosis and acquired immunodeficiency syndrome: a historical perspective on recent developments. Am J Med 1994;96:439–50.CrossRefGoogle Scholar
Havlir, D V, Barnes, P F. Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med 1999;340:367–73.CrossRefGoogle ScholarPubMed
Hopewell P C. Tuberculosis and other mycobacterial diseases. In: Mason, R J, Broaddus, C, Murray, J F, Nadel, J A, eds, Murray and Nadel's textbook of respiratory medicine, 4th ed. Philadelphia: Elsevier Saunders, 2005:979–1043.Google Scholar
Horsburgh, C R Jr.Priorities for the treatment of latent tuberculosis infection in the United States. N Engl J Med 2004;350:2060–7.CrossRefGoogle ScholarPubMed
Jasmer, R M, Nahid, P, Hopewell, P C. Clinical practice. Latent tuberculosis infection. N Engl J Med 2002;347:1860–6.CrossRefGoogle ScholarPubMed
Jensen, P A, Lambert, L A, Iademarco, M F, et al. Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care settings, 2005. MMWR Recomm Rep 2005;54(17):1–141.Google ScholarPubMed
Marais, B J, Gie, R P, Schaaf, H S, et al. Childhood pulmonary tuberculosis: old wisdom and new challenges. Am J Respir Crit Care Med 2006;173:1078–90.CrossRefGoogle ScholarPubMed
Mayosi, B M, Ntsekhe, M, Volmink, J A, et al. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev 2002(4):CD000526.Google ScholarPubMed
Mazurek, G H, Jereb, J, Lobue, P, et al. Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium tuberculosis infection, United States. MMWR Recomm Rep 2005;54(RR-15):49–55.Google ScholarPubMed
Nahid, P, Daley, C L. Prevention of tuberculosis in HIV-infected patients. Curr Opin Infect Dis 2006;19:189–93.CrossRefGoogle ScholarPubMed
Nahid, P, Pai, M, Hopewell, P C. Advances in the diagnosis and treatment of tuberculosis. Proc Am Thorac Soc 2006;3:103–10.CrossRefGoogle ScholarPubMed
Piessens W F, Nardell E A. The pathogenesis of tuberculosis. In: Reichman, L B, Hershfield, E S, eds, Tuberculosis: a comprehensive international approach, 2nd ed. rev. New York: Marcel Dekker, 2000:241–60.Google Scholar
Prasad, K, Volmink, J, Menon, G R. Steroids for treating tuberculous meningitis. Cochrane Database Syst Rev 2000(3):CD002244.Google ScholarPubMed
Pratt, R, Robison, V, Navin, T, et al. Trends in tuberculosis incidence – United States 2006. MMWR 2007;56(11):245–50.Google Scholar
Trenton, A J, Currier, G W. Treatment of comorbid tuberculosis and depression. Primary care companion. J Clin Psychiatry 2001;3:236–43.Google Scholar
Small, P, Fujiwara, P.Management of tuberculosis in the United States. N Engl J Med 2001 Jul 19;345(3):189–200.CrossRefGoogle Scholar
Iseman, M D. A clinician's guide to tuberculosis. Philadelphia: Lippincott Williams & Wilkins, 2000.Google Scholar
Raviglione, M C, ed. Reishman and Hershfield's tuberculosis: a comprehensive international approach, 3rd ed. New York: Informa Healthcare, 2006.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

  • Tuberculosis
    • By Adithya Cattamanchi, Fellow in Pulmonary and Critical Care Medicine, University of California, San Francisco School of Medicine, San Francisco General Hospital, San Francisco, CA, Payam Nahid, Assistant Professor of Medicine, Division of Pulmonary and Critical Care, University of California, San Francisco School of Medicine, San Francisco General Hospital, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.034
Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

  • Tuberculosis
    • By Adithya Cattamanchi, Fellow in Pulmonary and Critical Care Medicine, University of California, San Francisco School of Medicine, San Francisco General Hospital, San Francisco, CA, Payam Nahid, Assistant Professor of Medicine, Division of Pulmonary and Critical Care, University of California, San Francisco School of Medicine, San Francisco General Hospital, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.034
Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

  • Tuberculosis
    • By Adithya Cattamanchi, Fellow in Pulmonary and Critical Care Medicine, University of California, San Francisco School of Medicine, San Francisco General Hospital, San Francisco, CA, Payam Nahid, Assistant Professor of Medicine, Division of Pulmonary and Critical Care, University of California, San Francisco School of Medicine, San Francisco General Hospital, San Francisco, CA
  • Edited by Rachel L. Chin, University of California, San Francisco
  • Book: Emergency Management of Infectious Diseases
  • Online publication: 15 December 2009
  • Chapter DOI: https://doi.org/10.1017/CBO9780511547454.034
Available formats
×